Functional studies on cell line models identified associations between reduced CLDN3 expression and various cancer driving mechanisms such as a decrease in epithelial barrier function [43], invasiveness [43], dedifferentiation [43], proliferative potential [44], and reduced adhesion [40]. This evidence concerns the gene CLDN3 and cancer.